中集安瑞科(03899.HK)附屬研發疫苗儲存相關技術
中集安瑞科(03899.HK)公布,旗下中集聖達因近日著手研發針對生物醫療行業需求,適用於疫苗、幹細胞、血漿、精液、胚胎和各類組織器官等長期低溫儲存的液氮生物容器。
中集安瑞科總經理兼執行董事楊曉虎表示,國內外疫苗量產已經指日可待,但疫苗冷鏈儲運仍然是各國需要共同攻克的挑戰之一。公司看準疫情下所衍生的生物醫療低溫存儲設備需求,已開始加大此領域的研發投入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.